Skip to Content

Firmagon Approval History

  • FDA approved: Yes (First approved December 24th, 2008)
  • Brand name: Firmagon
  • Generic name: degarelix
  • Dosage form: for Injection
  • Company: Ferring Pharmaceuticals, USA
  • Treatment for: Prostate Cancer

Firmagon (degarelix) is an injectable gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for patients with advanced prostate cancer.

Development History and FDA Approval Process for Firmagon

Dec 29, 2008Approval FDA Approves Ferring Pharmaceuticals' Degarelix for Treatment of Advanced Prostate Cancer

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.